Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12,296 GBX | -0.87% | +1.54% | +16.00% |
10:23am | Monetary policy still drives investor sentiment | |
09:57am | AstraZeneca: favorable results in bronchial cancer | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.00% | 243B | |
+38.51% | 727B | |
+32.37% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+8.13% | 205B | |
-5.89% | 203B | |
+6.19% | 164B | |
+0.31% | 164B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca's Rare Progressive Disease Drug Granted US FDA Orphan Drug Tag